Immunosupression and infection after major surgery: A nutritional deficiency

Critical Care Clinics

Volumn 26, Issue 3, 2010, Pages 491-500

  Zhu, Xinmei ^a   Herrera, Gabriel ^a   Ochoa, Juan B ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Arginine; Arginine deficiency syndrome; Immunosuppression; Nutrition deficiency; T cell dysfunction

Indexed keywords

ANTIOXIDANT; ARGINASE 1; ARGININE; CD4 ANTIGEN; CD8 ANTIGEN; NITRIC OXIDE; NUCLEOTIDE DERIVATIVE; OMEGA 3 FATTY ACID;

ADAPTIVE IMMUNITY; ARGININE DEFICIENCY; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; COST; CRITICAL ILLNESS; DEATH; DIET SUPPLEMENTATION; DIETARY INTAKE; ELECTIVE SURGERY; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; INFECTION RISK; INFECTION SENSITIVITY; INNATE IMMUNITY; MAJOR SURGERY; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; NUTRITIONAL DEFICIENCY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; SEPSIS; SURGICAL PATIENT; T LYMPHOCYTE;

BACTERIAL INFECTIONS; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNE TOLERANCE; MULTIPLE ORGAN FAILURE; NUTRITION THERAPY; POSTOPERATIVE COMPLICATIONS; T-LYMPHOCYTES;

EID: 77954895585     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2010.04.004     Document Type: Review

References (39)

1. Mannick J.A., Rodrick M.L., Lederer J.A. The immunologic response to injury. J Am Coll Surg 2001, 193:237-244.
2. Beale R.J., Bryg D.J., Bihari D.J. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999, 27:2799-2805.
3. Daly J.M., Lieberman M.D., Goldfine J., et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 1992, 112:56-67.
4. Tepaske R., Velthuis H., Oudemans-van Straaten H.M., et al. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial. Lancet 2001, 358:696-701.
5. Heyland D.K., Novak F., Drover J.W., et al. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001, 286:944-953.
6. Popovic P.J., Zeh H.J., Ochoa J.B. Arginine and immunity. J Nutr 2007, 137:1681S-1686S.
7. Bronte V., Serafini P., Mazzoni A., et al. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol 2003, 24:302-306.
8. Morris S.M. Regulation of arginine availability and its impact on NO synthesis. Nitric oxide: biology and pathobiology 2000, 187-197. Academic Press, San Diego (CA). L.J. Ignarro (Ed.).
9. Morris S.M. Arginine: beyond protein. Am J Clin Nutr 2006, 83:508S-512S.
10. Seifter E., Rettura G., Barbul A., et al. Arginine: an essential amino acid for injured rats. Surgery 1978, 84:224-230.
11. Wakabayashi Y., Yamada E., Yoshida T., et al. Arginine becomes an essential amino acid after massive resection of rat small intestine. J Biol Chem 1994, 269:32667-32671.
12. Barbul A., Wasserkrug H.L., Seifter E., et al. Immunostimulatory effects of arginine in normal and injured rats. J Surg Res 1980, 29:228-235.
13. Ochoa J.B., Udekwu A.O., Billiar T.R., et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991, 214:621-626.
14. Tsuei B.J., Bernard A.C., Barksdale A.R., et al. Supplemental enteral arginine is metabolized to ornithine in injured patients. J Surg Res 2005, 123:17-24.
15. Jacob T.D., Ochoa J.B., Udekwu A.O., et al. Nitric oxide production is inhibited in trauma patients. J Trauma 1993, 35:590-596. [discussion: 596-7].
16. Lovett J.E., Fink B.F., Bernard A., et al. Analysis of nitric oxide activity in prevention of reperfusion injury. Ann Plast Surg 2001, 46:269-273.
17. Ochoa J.B., Strange J., Kearney P., et al. Effects of L-arginine on the proliferation of T lymphocyte subpopulations. JPEN J Parenter Enteral Nutr 2001, 25:23-29.
18. Ochoa J.B., Makarenkova V. T lymphocytes. Crit Care Med 2005, 33:S510-S513.
19. Zea A.H., Rodriguez P.C., Culotta K.S., et al. L-arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. Cell Immunol 2004, 232:21-31.
20. Rodriguez P.C., Zea A.H., DeSalvo J., et al. L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol 2003, 171:1232-1239.
21. Taheri F., Ochoa J.B., Faghiri Z., et al. L-arginine regulates the expression of the T cell receptor zeta chain (CD3zeta) in Jurkat cells. Clin Cancer Res 2001, 7:958s-965s.
22. Rodriguez P.C., Ochoa A.C. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev 2008, 222:180-191.
23. Ochoa A.C., Zea A.H., Hernandez C., et al. Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res 2007, 13:721s-726s.
24. Makarenkova V.P., Bansal V., Matta B.M., et al. CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol 2006, 176:2085-2094.
25. Gabrilovich D.I., Bronte V., Chen S.H., et al. The terminology issue for myeloid-derived suppressor cells. Cancer Res 2007, 67:425.
26. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009, 9:162-174.
27. Bronte V., Serafini P., Apolloni E., et al. Tumor-induced immune dysfunctions caused by myeloid suppressor cells. J Immunother 2001, 24:431-446.
28. Barksdale A.R., Bernard A.C., Maley M.E., et al. Regulation of arginase expression by T helper II cytokines and isoproterenol. Surgery 2004, 135:527-535.
29. Bernard A.C., Fitzpatrick E.A., Maley M.E., et al. Beta adrenoceptor regulation of macrophage arginase activity. Surgery 2000, 127(4):412-418.
30. Rodriguez P.C., Hernandez C.P., Quiceno D., et al. Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J Exp Med 2005, 202:931-939.
31. Bansal V., Ochoa J.B. Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care 2003, 6:223-228.
32. Bansal V., Syres K.M., Makarenkova V., et al. Interactions between fatty acids and arginine metabolism: implications for the design of immune-enhancing diets. JPEN J Parenter Enteral Nutr 2005, 29:S75-S80.
33. Okamoto Y., Okano K., Izuishi K., et al. Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and omega-3 fatty acids supplemented immunonutrition. World J Surg 2009, 33:1815-1821.
34. Mirza N., Fishman M., Fricke I., et al. All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Res 2006, 66:9299-9307.
35. Ochoa J.B., Makarenkova V., Bansal V. A rational us of immune enhancing diets: when should we use dietary arginine supplementation?. Nutr Clin Pract 2004, 19(3):216-225.
36. Ochoa J.B. Separating pharmaconutrition from classic nutrition goals: a necessary step. Crit Care Med 2008, 36:347-348.
37. Braga M., Gianotti L., Radaelli G., et al. Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg 1999, 134:428-433.
38. Braga M., Gianotti L., Vignali A., et al. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 2002, 132:805-814.
39. Kudsk K.A., Minard G., Croce M.A., et al. A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications. Ann Surg 1996, 224:531-540.